ServiceNow vs. UiPath: Which AI Stock Is a Better Buy in 2026?

The article favors ServiceNow for a five-year-plus holding, citing fiscal 2025 revenue growth of 20.9% to nearly $13.3B, about $1.75B in net income, and AI products exceeding $1B in annual contract value in Q2. The recommendation is tempered by its $7.75B Armis acquisition, total debt rising to about $7.5B by June 30, 2026, and expected gross-margin pressure from heavier AI usage. UiPath grew fiscal 2026 revenue 12.7% to about $1.6B and reported $282.3M net income, but about $204.9M came from a one-time tax valuation allowance release; the article notes slower growth despite its debt-free balance sheet and lower valuation.

Analysis

The key question is whether AI automation accrues to the workflow owner or to specialist execution tools. ServiceNow has the stronger position if enterprises want a governed control plane spanning departments; that can make its platform harder to displace and support cross-selling. But AI usage can raise serving and implementation costs before contract value converts into durable revenue, so headline AI contract value is not yet proof of incremental margin dollars. Armis and Veza could deepen security-led entry points, while also adding integration demands and leverage that may constrain flexibility if growth disappoints.

UiPath faces a less favorable second-order risk: Microsoft, Oracle, SAP and Salesforce can bundle agent and automation features into broader suites, pressuring standalone pricing and renewal economics. Snowflake partnerships may help UiPath reach data-rich workflows, but do not by themselves establish durable differentiation. Its reported profitability and cash generation also deserve a quality discount: the tax benefit dominates net income, while SBC is a large share of operating cash flow at both companies. That makes PATH’s cheaper multiples less decisive than they appear, though a valuation discount can already price in slow growth.

Near term, NOW’s premium leaves it exposed to margin or integration disappointments; PATH can outperform sharply if customer additions and organic growth reaccelerate. Over 1–3 months, watch NOW’s gross-margin trajectory, AI contract conversion and debt metrics, and PATH’s customer growth and subscription trends. Over 6–18 months, the test is whether AI expands paid workflow usage faster than compute costs and platform bundling erode economics. The relative thesis fails if NOW’s growth or margins deteriorate while PATH demonstrates sustained acceleration.

Key Decisions for Investors

• Prefer NOW to PATH on a relative, staged basis rather than treating the valuation gap alone as a buy signal. A modest long NOW / short PATH pair is reasonable only with controlled gross exposure: NOW retains premium-multiple risk, and PATH’s discount leaves room for a sharp catch-up rally.
• Add to NOW only as quarterly evidence confirms that AI contract value converts into revenue without worsening gross-margin trends and that Armis/Veza integration is progressing alongside manageable debt. Reassess if margins weaken or leverage remains elevated without corresponding growth contribution.
• Keep PATH on a catalyst watch rather than shorting aggressively at the current discount. Upgrade the view if customer growth and core subscription momentum reaccelerate; downgrade further if large-suite bundling coincides with slowing renewals or weaker organic growth.
• Monitor MSFT, ORCL, SAP and CRM product launches and customer adoption for evidence that bundled agents are substituting for specialist automation. For both names, evaluate cash generation after considering SBC rather than relying on headline free cash flow.